Involvement of histaminergic receptor mechanisms in the stimulation of NT-3 synthesis in astrocytes |
| |
Authors: | Jurič Damijana M Mele Tina Carman-Kržan Marija |
| |
Affiliation: | Department of Pharmacology and Experimental Toxicology, University of Ljubljana, Korytkova 2, SI-1000 Ljubljana, Slovenia. damijana-mojca.juric@mf.uni-lj.si |
| |
Abstract: | Neurotrophin-3 (NT-3) is produced by astrocytes, in addition to neurons, and monoamine neurotransmitters play a role in controlling NT-3 synthesis. The impact of histamine (HA) on the regulation of NT-3 synthesis in cultured astrocytes has not been studied. We evaluated the involvement of histamine receptors and intracellular mechanisms in the regulation of NT-3 production by HA. Real-time PCR was performed to examine the expression of all known histamine receptor subtypes in cultured rat cortical astrocytes. Pharmacological tools, selective for the H?, H? and H? receptors and intracellular systems, were utilized to confirm functional properties of HA receptors in histaminergic up-regulation of astrocytic NT-3 synthesis. HA potently and transiently elevated NT-3 expression and protein levels by more than twofold. In addition to H? and H? receptors, cultured astrocytes also express H? receptors, which activate G(i/o) proteins to inhibit adenylyl cyclase and modulate MAP kinase activity. Histaminergic stimulation was partly inhibited by selective H?, H?, and H? antagonists whereas selective H?, H?, and H? agonists or mediators of the intracellular histaminergic pathways increased NT-3 levels. Inhibitors of PKA, PKC, and CaMK II significantly reduced the HA-induced increase in NT-3 cellular levels whereas the MAP kinase cascade inhibitor completely blocked the stimulatory action of HA and all selective agonists. In conclusion, the synthesis of astrocytic NT-3 stimulated by HA is a receptor-mediated process, which is fine-tuned via subtle modulation of parallel histaminergic H?, H?, and H? pathways that converge at the level of MAP kinase activity. This article is part of a Special Issue entitled 'Trends in neuropharmacology: in memory of Erminio Costa'. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|